{"id":"https://openalex.org/W2063654089","doi":"https://doi.org/10.1002/cncr.11563","title":"Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma","display_name":"Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma","publication_year":2003,"publication_date":"2003-06-12","ids":{"openalex":"https://openalex.org/W2063654089","doi":"https://doi.org/10.1002/cncr.11563","mag":"2063654089","pmid":"https://pubmed.ncbi.nlm.nih.gov/12910529"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.11563","doi":"https://doi.org/10.1002/cncr.11563","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.11563","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085557593","display_name":"Caroline Laverdi\u00e8re","orcid":"https://orcid.org/0000-0002-4917-7152","observed_orcids":["https://orcid.org/0000-0002-4917-7152"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caroline Laverdiere","raw_affiliation_strings":["Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA","Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009981843","display_name":"Edward Anders Kolb","orcid":"https://orcid.org/0000-0003-2854-9014","observed_orcids":["https://orcid.org/0000-0003-2854-9014"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Anders Kolb","raw_affiliation_strings":["Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089509810","display_name":"Jeffrey G. Supko","orcid":"https://orcid.org/0000-0002-4599-3267","observed_orcids":["https://orcid.org/0000-0002-4599-3267"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey G. Supko","raw_affiliation_strings":["Division of Hematology Oncology, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology Oncology, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032743242","display_name":"Richard Greg Gorlick","orcid":"https://orcid.org/0000-0001-8995-2929","observed_orcids":["https://orcid.org/0000-0001-8995-2929"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard Gorlick","raw_affiliation_strings":["","Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010913859","display_name":"Paul A. Meyers","orcid":"https://orcid.org/0000-0001-6146-6101","observed_orcids":["https://orcid.org/0000-0001-6146-6101"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul A. Meyers","raw_affiliation_strings":["Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068677359","display_name":"Robert G. Maki","orcid":"https://orcid.org/0000-0002-9853-2528","observed_orcids":["https://orcid.org/0000-0002-9853-2528"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert G. Maki","raw_affiliation_strings":["Division of Medical Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York","Robert G. Maki, M.D., received funding to research studies from PharmaMar, Inc. and the National Cancer Institute (NCI Program Project Grant P01-CA47179)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Robert G. Maki, M.D., received funding to research studies from PharmaMar, Inc. and the National Cancer Institute (NCI Program Project Grant P01-CA47179)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080725919","display_name":"Leonard H. Wexler","orcid":"https://orcid.org/0000-0003-0724-8263","observed_orcids":["https://orcid.org/0000-0003-0724-8263"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leonard Wexler","raw_affiliation_strings":["Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060580923","display_name":"George D. Demetri","orcid":"https://orcid.org/0000-0002-0045-4809","observed_orcids":["https://orcid.org/0000-0002-0045-4809"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George D. Demetri","raw_affiliation_strings":["Division of Hematology Oncology, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts","George D. Demetri, M.D., received support for research and consulting (within acceptable Harvard conflict of interest rules) from corporate entities that currently are developing ET-743 (PharmaMar and Johnson & Johnson)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology Oncology, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"George D. Demetri, M.D., received support for research and consulting (within acceptable Harvard conflict of interest rules) from corporate entities that currently are developing ET-743 (PharmaMar and Johnson & Johnson)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022207361","display_name":"John H. Healey","orcid":"https://orcid.org/0000-0002-0802-1186","observed_orcids":["https://orcid.org/0000-0002-0802-1186"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John H. Healey","raw_affiliation_strings":["Division of Orthopedic Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Orthopedic Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017081282","display_name":"Andrew G. Huvos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew G. Huvos","raw_affiliation_strings":["Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054775619","display_name":"Allen M. Goorin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allen M. Goorin","raw_affiliation_strings":["Division of Hematology Oncology, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology Oncology, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036062620","display_name":"Rochelle Bagatell","orcid":"https://orcid.org/0000-0002-5729-8819","observed_orcids":["https://orcid.org/0000-0002-5729-8819"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rochelle Bagatell","raw_affiliation_strings":["Department of Pediatrics, University of Arizona Health Sciences Center, Tucson, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, University of Arizona Health Sciences Center, Tucson, Arizona","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028936344","display_name":"Ana Ruiz\u2010Casado","orcid":"https://orcid.org/0000-0002-7672-2638","observed_orcids":["https://orcid.org/0000-0002-7672-2638"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Ruiz\u2010Casado","raw_affiliation_strings":["Ana Ruiz-Casado, M.D., is employed as a medical oncologist for PharmaMar S. A","PharmaMar S. A., Tres Cantos, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ana Ruiz-Casado, M.D., is employed as a medical oncologist for PharmaMar S. A","institution_ids":["https://openalex.org/I4210116403"]},{"raw_affiliation_string":"PharmaMar S. A., Tres Cantos, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113687916","display_name":"Cecilia Guzm\u00e1n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cecilia Guzman","raw_affiliation_strings":["Cecilia Guzman, M.D., was a full-time employee of PharmaMar S. A. during the course of the current study","PharmaMar S. A., Tres Cantos, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cecilia Guzman, M.D., was a full-time employee of PharmaMar S. A. during the course of the current study","institution_ids":["https://openalex.org/I4210116403"]},{"raw_affiliation_string":"PharmaMar S. A., Tres Cantos, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105422457","display_name":"Jos\u00e9 Mar\u00eda Jimeno","orcid":"https://orcid.org/0009-0004-1095-1990","observed_orcids":["https://orcid.org/0009-0004-1095-1990"]},"institutions":[{"id":"https://openalex.org/I4210116403","display_name":"PharmaMar (Spain)","ror":"https://ror.org/02h694m69","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210116403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose Jimeno","raw_affiliation_strings":["Jose Jimeno, M.D., is Vice President of Scientific Development for PharmaMar S. A. and is a stockholder in the company","PharmaMar S. A., Tres Cantos, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jose Jimeno, M.D., is Vice President of Scientific Development for PharmaMar S. A. and is a stockholder in the company","institution_ids":["https://openalex.org/I4210116403"]},{"raw_affiliation_string":"PharmaMar S. A., Tres Cantos, Spain","institution_ids":["https://openalex.org/I4210116403"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017550859","display_name":"David C. Harmon","orcid":"https://orcid.org/0000-0002-4181-0179","observed_orcids":["https://orcid.org/0000-0002-4181-0179"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Harmon","raw_affiliation_strings":["Division of Hematology Oncology, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology Oncology, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210134579"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5032743242"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":6.7517,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.96943168,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"98","issue":"4","first_page":"832","last_page":"840"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10975","display_name":"Bone Tumor Diagnosis and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trabectedin","display_name":"trabectedin","score":0.9819999933242798},{"id":"https://openalex.org/keywords/recurrent-osteosarcoma","display_name":"recurrent osteosarcoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.9380000233650208},{"id":"https://openalex.org/keywords/heavily-pretreated-patients","display_name":"heavily pretreated patients","score":0.9399999976158142},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8379999995231628},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5730000138282776},{"id":"https://openalex.org/keywords/hepatic-transaminase-elevation","display_name":"hepatic transaminase elevation","score":0.9110000133514404},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9269999861717224},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9409999847412109},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8450000286102295},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9173704981803894},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7746371030807495},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6231968402862549},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5753899812698364},{"id":"https://openalex.org/C2777760704","wikidata":"https://www.wikidata.org/wiki/Q549534","display_name":"Osteosarcoma","level":2,"score":0.5340731739997864},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5275087952613831},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5117404460906982},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.46303945779800415},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.45009148120880127},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07700484991073608}],"mesh":[{"descriptor_ui":"D000077606","descriptor_name":"Trabectedin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004149","descriptor_name":"Dioxoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004149","descriptor_name":"Dioxoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004149","descriptor_name":"Dioxoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cncr.11563","doi":"https://doi.org/10.1002/cncr.11563","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cncr.11563","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:12910529","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12910529","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G6730169073","display_name":"Soft Tissue Sarcoma Program Project","funder_award_id":"P01CA047179","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1513901790","https://openalex.org/W1545401674","https://openalex.org/W1583178330","https://openalex.org/W1863005346","https://openalex.org/W1977447667","https://openalex.org/W1985806831","https://openalex.org/W1994305568","https://openalex.org/W1995465345","https://openalex.org/W1998191384","https://openalex.org/W1999312745","https://openalex.org/W2001272995","https://openalex.org/W2003174619","https://openalex.org/W2013955518","https://openalex.org/W2014591827","https://openalex.org/W2018169190","https://openalex.org/W2018217408","https://openalex.org/W2042655580","https://openalex.org/W2056068172","https://openalex.org/W2073867312","https://openalex.org/W2080637828","https://openalex.org/W2097904291","https://openalex.org/W2099134833","https://openalex.org/W2105509900","https://openalex.org/W2109801148","https://openalex.org/W2120685711","https://openalex.org/W2121855567","https://openalex.org/W2121943967","https://openalex.org/W2128260825","https://openalex.org/W2129825675","https://openalex.org/W2138266786","https://openalex.org/W2146989709","https://openalex.org/W2148630845","https://openalex.org/W2148820749","https://openalex.org/W2151644755","https://openalex.org/W2153737617","https://openalex.org/W2154442487","https://openalex.org/W2161522889","https://openalex.org/W2164131588","https://openalex.org/W2169287543","https://openalex.org/W2243561273","https://openalex.org/W2259822917","https://openalex.org/W2262986705","https://openalex.org/W2321597617","https://openalex.org/W2339300075","https://openalex.org/W2411380402","https://openalex.org/W2435012681","https://openalex.org/W2918125916","https://openalex.org/W4231148876","https://openalex.org/W4239752228"],"related_works":["https://openalex.org/W1903528106","https://openalex.org/W88629896","https://openalex.org/W2157598836","https://openalex.org/W1996262472","https://openalex.org/W7100398663","https://openalex.org/W2262986705","https://openalex.org/W2143530174","https://openalex.org/W2123302336","https://openalex.org/W2107078868","https://openalex.org/W7096203923"],"abstract_inverted_index":{"BACKGROUND:":[0],"Recurrent":[1],"osteosarcoma":[2,38,267],"is":[3],"a":[4,8,28,51,57,138,275],"drug-resistant":[5],"disease":[6],"with":[7,36,282],"dismal":[9],"prognosis.":[10],"The":[11,91,179,278],"objective":[12],"of":[13,23,53,77,85,94,112,141,280],"this":[14],"Phase":[15],"II":[16],"study":[17],"was":[18,48,98,116,158,199,215,258],"to":[19,102,149,260],"evaluate":[20],"the":[21,68,150,183,211],"activity":[22,273],"ecteinascidin":[24],"743":[25],"(ET-743)":[26],"as":[27,56,274],"salvage":[29],"therapy":[30],"in":[31,170,186,207,264],"these":[32],"patients.":[33],"METHODS:":[34],"Patients":[35],"recurrent":[37],"who":[39],"had":[40,270],"received":[41],"standard":[42],"chemotherapeutic":[43,96],"agents":[44,97],"were":[45,65,74,79,108,168,240],"eligible.":[46],"ET-743":[47,257,281],"administered":[49,109],"at":[50],"dose":[52],"1500":[54],"microg/m(2)":[55],"24-hour":[58],"infusion":[59],"every":[60],"3":[61,145,162,217],"weeks.":[62],"Pharmacokinetic":[63],"studies":[64],"performed":[66],"during":[67],"first":[69],"cycle.":[70],"RESULTS:":[71],"Twenty-five":[72],"patients":[73,124,135,172,176,188,268],"enrolled,":[75],"23":[76],"whom":[78,210],"assessable":[80],"for":[81,209],"response":[82],"(median":[83,110],"age":[84],"18":[86],"years;":[87],"range,":[88,118],"12-67":[89],"years).":[90],"median":[92],"number":[93,111],"previous":[95,104],"five":[99],"(range,":[100],"three":[101],"eight":[103],"agents).":[105],"Sixty-one":[106],"cycles":[107,113,120],"per":[114,121],"patient":[115,250],"2;":[117],"1-9":[119],"patient).":[122],"Three":[123],"(12%)":[125],"achieved":[126],"minor":[127],"responses":[128],"(49%":[129],"36%":[130],"and":[131,166,174,249],"25%,":[132],"respectively).":[133],"Fifteen":[134],"(60%)":[136],"developed":[137],"transient":[139],"elevation":[140],"hepatic":[142],"transaminases":[143],"(Grade":[144],"or":[146,163,227,253,284],"4":[147,164,187,191],"[according":[148],"National":[151],"Cancer":[152],"Institute":[153],"Common":[154],"Toxicity":[155],"Criteria]),":[156],"which":[157],"not":[159],"cumulative.":[160],"Grade":[161,190,216,228],"neutropenia":[165],"thrombocytopenia":[167],"observed":[169],"12":[171],"(48%)":[173],"6":[175],"(24%),":[177],"respectively.":[178],"mean":[180],"area":[181],"under":[182],"curve":[184],"(AUC)":[185],"experiencing":[189],"toxicity":[192,214],"(76.4":[193],"+/-":[194,219,231],"29.3":[195],"ng":[196,221,233],"x":[197,222,234],"hr/mL)":[198],"significantly":[200],"greater":[201],"(P":[202],"=":[203,225,237],"0.034)":[204],"than":[205],"that":[206],"those":[208],"most":[212],"severe":[213],"(39.5":[218],"17.2":[220],"hr/mL":[223,235],"[n":[224,236],"12])":[226],"1-2":[229],"(52.6":[230],"15.6":[232],"5]).":[238],"There":[239],"no":[241],"other":[242],"significant":[243],"correlations":[244],"found":[245,259],"between":[246],"pharmacokinetic":[247],"variables":[248],"characteristics,":[251],"toxicity,":[252],"therapeutic":[254],"response.":[255],"CONCLUSIONS:":[256],"be":[261,287],"well":[262],"tolerated":[263],"heavily":[265],"pretreated":[266],"but":[269],"limited":[271],"antitumor":[272],"single":[276],"agent.":[277],"combination":[279],"cisplatin":[283],"doxorubicin":[285],"should":[286],"considered.":[288]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}